Philips and Cognizant Collaborate in Digital Health
Royal Philips and Cognizant have announced a collaboration to develop end-to-end digital health solutions that will aim to enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials. The alliance brings together Philips HealthSuite, a cloud-based platform and Cognizant’s digital engineering knowledge to deliver and maintain digital health solutions at scale, providing advanced connectivity and using big data to create actionable insights.
Philips HealthSuite, built on Amazon Web Services, is an integrated, modular set of standards-based capabilities that support the development of digital health propositions. The platform securely stores critical healthcare data and provides both advanced data analytics and AI capabilities. To date, more than 100 types of medical devices have been integrated into HealthSuite, with over 145 billion clinical images securely archived on the cloud platform. As part of this collaboration, Cognizant will build, deploy, implement, and operate client-specific applications on Philips HealthSuite.
With these solutions, healthcare providers can monitor their patients outside traditional clinical settings, and patients can stay more informed of their own well-being.
For more information, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
